Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Ensysce Biosciences Inc (ENSC)

$0.28 +0.03 (10.71%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	3.89M
Revenue (ttm)	5.07M
Net Income (ttm)	-10.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-200.79%
Debt to Equity Ratio	0.00

Volume	120,180,305
Avg Vol	3,565,682
Day's Range	N/A - N/A
Shares Out	15.37M
Stochastic %K	74%
Beta	0.78
Analysts	Strong Buy
Price Target	$16.45

Company Profile

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 263 4196

Website: www.ensysce.com

Address:

7946 Ivanhoe Avenue, Suite 201, La Jolla, United States

Easteregg Aug. 4 at 2:22 PM

$ENSC Gettin rekt.

0 · Reply

Pelicanos Aug. 4 at 2:20 PM

$ENSC

0 · Reply

DjStockTrades Aug. 4 at 2:20 PM

$HTCR watch if this breaks 2.80 range. $ADGM $TNMG $ENSC

0 · Reply

NewDeal Aug. 4 at 2:18 PM

$ENSC Funny! LMAO Hahahahahah. If you're done, move on and stop clogging up the board.

0 · Reply

TradeForLifeKing Aug. 4 at 2:14 PM

$ENSC just beginning here, double digits very possible 👍

1 · Reply

M113 Aug. 4 at 2:14 PM

$ENSC done folks

0 · Reply

BlazeofFury Aug. 4 at 2:13 PM

$VGAS here we goo breaking out. $NUWE $ENSC $DFNS

1 · Reply

topstockalerts Aug. 4 at 2:13 PM

Top Gainers $QNME $ADGM $TNMG $AMIX $ENSC

0 · Reply

Barryman1 Aug. 4 at 2:12 PM

$ENSC it will No worries I help pushing by buying

1 · Reply

StockAuthority Aug. 4 at 2:11 PM

$ENSC boom on vacation and STILL got TWO 70% winners in the first two days! Keep those alerts on !! ‼️ $VMAR is next up for news that can also move it about the same as these…

0 · Reply

Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology

Ensysce Biosciences initiates review of strategic alternatives

2026-02-25T13:17:50.000Z - 5 months ago

Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain

Ensysce Biosciences expands global opioid patent portfolio

2026-01-21T13:15:40.000Z - 6 months ago

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

Ensysce Biosciences Transcript: AGM 2025

Jan 7, 2026, 12:00 PM EST - 7 months ago

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid

Ensysce Biosciences files to sell 4.6M shares of common stock for holders

2025-12-02T22:00:54.000Z - 8 months ago

Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs

Ensysce Biosciences Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 4:15 PM EST - 9 months ago

Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse

Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2

Jun 24, 2025, 8:00 AM EDT - 1 year ago

Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain

Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 10, 2025, 4:15 PM EDT - 1 year ago

Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids

Feb 5, 2025, 8:00 AM EST - 1 year ago

Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment

Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR

Jan 22, 2025, 8:00 AM EST - 1 year ago

0 · Reply

Pelicanos Aug. 4 at 2:20 PM

$ENSC

0 · Reply

DjStockTrades Aug. 4 at 2:20 PM

$HTCR watch if this breaks 2.80 range. $ADGM $TNMG $ENSC

0 · Reply

NewDeal Aug. 4 at 2:18 PM

$ENSC Funny! LMAO Hahahahahah. If you're done, move on and stop clogging up the board.

0 · Reply

TradeForLifeKing Aug. 4 at 2:14 PM

$ENSC just beginning here, double digits very possible 👍

1 · Reply

M113 Aug. 4 at 2:14 PM

$ENSC done folks

0 · Reply

BlazeofFury Aug. 4 at 2:13 PM

$VGAS here we goo breaking out. $NUWE $ENSC $DFNS

1 · Reply

topstockalerts Aug. 4 at 2:13 PM

Top Gainers $QNME $ADGM $TNMG $AMIX $ENSC

0 · Reply

Barryman1 Aug. 4 at 2:12 PM

$ENSC it will No worries I help pushing by buying

1 · Reply

StockAuthority Aug. 4 at 2:11 PM

$ENSC boom on vacation and STILL got TWO 70% winners in the first two days! Keep those alerts on !! ‼️ $VMAR is next up for news that can also move it about the same as these…

0 · Reply